THE EFFECT OF BISOPROLOL ON DISEASE COURSE FOR PATIENTS WITH HIGH SST2 LEVELS AND ACUTE MYOCARDIAL INFARCTION


  • N. P. Kopytsya Government institution «L.T.Malaya Therapy National Institute of the National Academy of Medical Science of Ukraine», Ukraine
  • Ya. V. Hilova Government institution «L.T.Malaya Therapy National Institute of the National Academy of Medical Science of Ukraine», Ukraine
  • A.V. Kobets Government institution «L.T.Malaya Therapy National Institute of the National Academy of Medical Science of Ukraine», Ukraine
Keywords: sST2, аcute myocardial infarction, beta-blockers, bisoprolol

Abstract

THE EFFECT OF BISOPROLOL ON DISEASE COURSE FOR PATIENTS WITH HIGH SST2 LEVELS AND ACUTE  MYOCARDIAL  INFARCTION

References

1. Januzzi J L., Pascual-FigalD, DanielsLB. ST2 Testing for Chronic Heart Failure Therapy Monitoring: The International ST2 Consensus Panel. Journal of the American College of Cardiology. 2015; 115 (7Suppl):70B-5B.

2. López-SendónJ, SwedbergK, McMurrayJ, etal. Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J.2004; 25:1341.

3. Miller A.M. Role of IL-33 in inflammation and disease. J. Inflamm. (Lond).2011; 8 (1): 22-26.

4. Mueller T., Dieplinger B., A. Gegenhuber et al. Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure. Clin. Chem. 2008; 54: 752-756.

5. Weinberg E.O., Shimpo M., Hurwitz S. et al. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation. 2003; 107: 721-726.
Published
2018-11-15
How to Cite
Kopytsya, N. P., Hilova, Y. V., & Kobets, A. (2018). THE EFFECT OF BISOPROLOL ON DISEASE COURSE FOR PATIENTS WITH HIGH SST2 LEVELS AND ACUTE MYOCARDIAL INFARCTION. Biological Markers in Fundamental and Clinical Medicine (scientific Journal), 2(2), 27-28. https://doi.org/10.29256/v.02.02.2018.escbm20
Section
Selected abstracts